BioNano Genomics (BNGO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

BioNano Genomics (BNGO) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

BioNano Genomics

· BNGO

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

20.374 M

-9.83%

General

Market Cap: $20.37M
Enterprise Value: $20.88M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 47.50%
Operating Margin: -106.67%
Net Profit Margin: -106.58%
FCF Margin: -67.87%
ROA: -67.58%
ROE: -78.78%
ROIC: -83.76%
Current Ratio: 2.48
Debt-to-Equity: 0.21
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 0.59
P/FCF: —
P/B: 0.57
EV/EBITDA: -0.93

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 13.91%
Rev 3Y (CAGR): 0.84%
Rev 5Y (CAGR): 27.37%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $30.18M
Gross Margin: 47.50%
Operating Expenses: $46.52M
Operating Income: -$32.19M
Net Profit: -$32.16M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $3.73M
Working Capital: $14.84M
Total Assets: $47.59M
Net Debt: $2.97M
Total Liabilities: $15.99M
Total Equity: $31.61M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$20.48M
Cash Flow from Investing: $18.48M
Cash Flow from Financing: $2.64M
Free Cash Flow: -$20.48M
Capital Expenditures: $0